Zobrazeno 1 - 10
of 87
pro vyhledávání: '"K. Alimoghadam"'
Autor:
M. Iravani, B. Mohebbi, B. Bahar, K. Alimoghadam, A. Moosavi, S. Najar-Najafi, A. Ardalan A. Ghavamzadeh
Publikováno v:
Acta Medica Iranica, Vol 43, Iss 3, Pp 177-181 (2005)
Interleukin-10 (IL-10) is a potent immunosuppressor which inhibits alloantigenic T cell response. IL-10 is also an anti-inflammatory endogenous cytokine. To investigate the predictive significance of endogenous IL-10 for acute graft versus host disea
Externí odkaz:
https://doaj.org/article/a67282888d5149ab8c639b78b469d8ca
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
SH Mousavi, Y Mortazavi, H Dargahi, N Shayan, K Alimoghadam, A Ghavamzadeh, M Iravani, SA Mousavi, SH Ghaffari
Publikováno v:
پیاورد سلامت, Vol 2, Iss 1, Pp 89-96 (2008)
Background & Aim : Chronic myeloid leukemia (CML) is a disorder of pluripotential hematopoietic stem cell that is as a myeloproliferative disease and occurs in about 15 percent of all leukemia. Two cell cycle regulatory proteins that function as tumo
Externí odkaz:
https://doaj.org/article/d16249ccce57450585a34d999a6d3a42
Autor:
A Amini, SH Ghaffari, Y Mortazavi, N Eynolahi, K Alimoghadam, Sh Rostami, Y Gahani, A Ghavamzadeh
Publikováno v:
پیاورد سلامت, Vol 2, Iss 1, Pp 73-83 (2008)
Background and Aim: Chronic Myelogenous Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by a translocation between chromosome 9 and 22 called Philadelphia Chromosome. Telomerase- essential enzyme that adds telomeric repeats
Externí odkaz:
https://doaj.org/article/643a4b3ff2ac4578805f18b489239355
Publikováno v:
پیاورد سلامت, Vol 2, Iss 1, Pp 40-46 (2008)
Background and Aim: Acute promyelocytic leukemia (APL) is associated with the t(1517) ,fusing promyelocytic leukemia (PML) and retinoic acid receptor-a (RARa) genes. This disease is uniquely sensitive to treatment with all-trans retinoic acid (ATRA)
Externí odkaz:
https://doaj.org/article/765d10e1c7e64e55b8715fbbf4ae4229
Autor:
SA Mousavi, M Iravani, A Ghavamzadeh, K Alimoghadam, N Shayan, H Dargahi, Y Mortazavi, SH Mousavi, SH Ghaffari
Publikováno v:
پیاورد سلامت, Vol 2, Iss 1-2, Pp 89-96 (2008)
Background & Aim : Chronic myeloid leukemia (CML) is a disorder of pluripotential hematopoietic stem cell that is as a myeloproliferative disease and occurs in about 15 percent of all leukemia. Two cell cycle regulatory proteins that function as tumo
Externí odkaz:
https://doaj.org/article/111001309b9c4195b308e7a4b80159fb
Autor:
K Alimoghadam, N Eynolahi, Y Mortazavi, Sh Rostami, SH Ghaffari, A Amini, Y Gahani, A Ghavamzadeh
Publikováno v:
پیاورد سلامت, Vol 2, Iss 1-2, Pp 73-82 (2008)
Background and Aim: Chronic Myelogenous Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by a translocation between chromosome 9 and 22 called Philadelphia Chromosome. Telomerase- essential enzyme that adds telomeric repeats
Externí odkaz:
https://doaj.org/article/9690df1b3f834271a1e9c0293a8c3d8a
Publikováno v:
پیاورد سلامت, Vol 2, Iss 1-2, Pp 40-46 (2008)
Background and Aim: Acute promyelocytic leukemia (APL) is associated with the t(15;17) ,fusing promyelocytic leukemia (PML) and retinoic acid receptor-a (RARa) genes. This disease is uniquely sensitive to treatment with all-trans retinoic acid (ATRA)
Externí odkaz:
https://doaj.org/article/44f2bcae35034ee9a86132f53b9d479b
Autor:
Mojtaba Mojtahedzadeh, Kheirollah Gholami, A. Ghavamzadeh, Molouk Hadjibabaie, Ahmad Reza Shamshiri, Zahra Jahangard-Rafsanjani, Amir Sarayani, K Alimoghadam, M Ostadali-Dehaghi
Publikováno v:
Bone Marrow Transplantation. 48:832-836
Oral mucositis (OM) is a complication of high-dose chemotherapy (HDC) followed by hematopoietic SCT (HSCT) with few effective treatments. Selenium has a cytoprotective role via the glutathione peroxidase (Glu.Px) enzyme and prevents chemotherapy-indu
Autor:
Jafar Ai, J. Han, S. Kim, C. Ko, J. Park, X. Zheng, T. Kim, S. Abdul Hafid, K. Nesaretnam, A. Hayashi, L. Wu, M. Inoue, L. Adamson, H. Sato, M. Sadat, Kayhan Azadmanesh, Alireza Razavi, R. Vahab pour, Seungmin Baek, M. D. Roth, M. Lin, M. Hasegawa, A. Kanamoto, Kristina M. Jenkins, W. Shi, L. Hansson, S. Yamada, A. Harui, Jeffrey A. Medin, H. Park, M. Khamisabadi, S. M. Kiertscher, Afshin Namdar, H. Katano, Arash Pourgholaminejad, G. Segal, E. O. Akanni, Arezoo Jamali, H. Sohn, A. Amini, Y. Yoshikai, H. Ichikawa, M. Sato, M. Nourizadeh, C. W. Schmidt, J. Hajati, A. K. Radhakrishnan, E. Xu, X. Chen, F. Masoumi, J. A. M. Pichler, M. Li, M. Yoshinari, B. Garcia, Sherree Friend, J. K. Oloke, A. Amari, L. Salazar, Megan K. Levings, A. Pourfathollah, A. Österborg, Cindy Gutzeit, C. Duran, H. Mellstedt, S. K. Basak, Y. Zhang, S. Oh, D. Chen, E. A. Adebayo, S. Kwon, Jonathan L. Bramson, B. Näsman-Glaser, A. Memarnejad, X. Zhang, Morteza Samadi, Y. Yanagi, Hidetoshi Tahara, R. Maekawa, A. Itoh, H. Wang, H. Sasaki, M R Aghasadeghi, M. Palma, A. Scheynius, H. Asgarian, Susanne Gabrielsson, K. Sueishi, M. Minami, Q. Li, J. Koropatnick, K. Yokokawa, Y. Kim, M. Harada, H. Lee, T. Tamura, Roobina Boghozian, Sara M. Johansson, J. Lee, N. Jiang, N. Chou, K. Alimoghadam, I. O. Ola, M. Park, Jamshid Hadjati, Thaddeus C. George, M. Lopez, A. Shunnar, I. Pan, X. Jiang, C. Zhang, M. Yamamoto, B. Shan, I. Eriksson, M. Takahara, Helen Vallhov, F. Salazar-Onfray, M. Nieda, M. Tomiyama, J. Chen, C. Kim, W. Min, A. Y. Wang, Y. Yonemitsu, Sarah Q. Crome, Z. Xi, S. Okano, K. Bagheri, C. Hotta, H. Kim, Seyed Mohammad Moazzeni
Publikováno v:
International Immunology. 22:iv47-iv52